RE: Bid and share price stuck2 Sep 2022 10:43
Hmm I think you may well be right Lloyd. Means selling at 15p really isn’t such a bad idea after all as this will drop to about 10 or 11p if another cash raise is announced out of the blue. Budd obviously isn’t going to agree a price for dilution after he’s told us ‘sales have proved to be more of a challenge than we’d hoped’ or some such phrase, so I think you are likely on the money here Lloyd. Announce the raise, watch the sp drop by 40% then tell us of no sales but excitement about future prospects on AIHL and stroke tests and the emerging importance of genomic testing. If GDR isn’t bought out then I think it will be worth about 30 - 40p in 18 months time. Lths will just have to suffer a serious dip short term before it starts to recover, and that recovery will only start IF (there’s no guarantee) NICE publish a ‘best practice’ notification for AIHL in Sept/Oct 2023.